CoChat

Bioactive scaffolds for tissue engineering: A review of decellularized extracellular matrix applications and innovations

Open access

The DOI matches its Crossref record; 208 of the 210 references it cites were found in a registry or an index; 90 of the 191 sources its claims cite were checked for support.

Abstract

Decellularized extracellular matrix (dECM) offers a three-dimensional, non-immunogenic scaffold, enriched with bioactive components, making it a suitable candidate for tissue regeneration. Although dECM-based scaffolds have been successfully implemented in preclinical and clinical settings within tissue engineering and regenerative medicine, the mechanisms of tissue remodeling and functional restoration are not fully understood. This review critically assesses the state-of-the-art in dECM scaffolds, including decellularization techniques for various tissues, quality control and cross-linking. It highlights the functional properties of dECM components and their latest applications in multiorgan tissue engineering and biomedicine. Additionally, the review addresses current challenges and limitations of decellularized scaffolds and offers perspectives on future directions in the field.

Overview

CoChat Summary

## TL;DR

This review surveys decellularized extracellular matrix (dECM) scaffolds for tissue engineering, covering sources, decellularization methods, characterization, postprocessing, and applications. It argues that dECM’s preserved 3D structure and bioactive cues make it promising for regeneration, organ engineering, and disease models, while key hurdles remain in decellularization standardization, recellularization, and vascularization.

## Key findings

  • The authors report a Web of Science search for “Decellularized extracellular matrix” returned 5,458 scholarly works with 132,705 cumulative citations, showing rapid growth of the field.
  • dECM scaffolds preserve native-like ECM cues while removing immunogenic cellular material; the review states they can support cell adhesion, migration, proliferation, and differentiation and reduce adverse immune reactions after implantation.
  • In preclinical and clinical applications, dECM products and constructs are described for skin, musculoskeletal, cardiac, liver, kidney, lung, neural, bone, muscle, and organoid applications; examples named include AlloDerm, Oasis, GraftJacket, Allopatch HD, and CardioCel.
  • A major bottleneck is vascularization: the paper notes rat liver scaffolds had 8 h post-transplant survival, extended to 24 h with anticoagulants; re-cellularized rat lung tissues exchanged gas for 45–120 min and survived up to 3 days post-transplant, and a lung-derived scaffold with islet cells formed a functional organ after 7 days of culture.

## Methods

  • Narrative review article synthesizing prior studies on dECM sources, decellularization protocols, characterization techniques, postprocessing, and applications in tissue engineering and biomedicine.
  • The review draws on published examples across tissues and organs and summarizes decellularization approaches including physical, chemical, enzymatic, and hybrid methods.
  • It also reviews characterization and application literature using techniques such as histology, immunostaining, microscopy, mass spectrometry, PCR, Western blotting, SEM/TEM, OCT, AFM, and proteomics/matrisomics.

## Limitations

  • The paper states there is no universally accepted standard for decellularization because outcomes depend on tissue heterogeneity such as species, age, anatomical site, and size.
  • It explicitly notes unresolved challenges in incomplete cellular removal, preservation of ECM bioactivity, structural integrity, vascularization, microbial contamination, complexity, and scalability.
  • Evident from the text: this is a review, so it does not present a single primary experimental dataset or a new comparative trial; instead it compiles prior studies and examples.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1002/exp.20230078

Cites

208 of 208 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

FIGURE 1 The development trend of dECM scaffolds. (A) Global trends and (B) research directions in publications and citations of decellularized extracellular matrix analysis in Web of Science from 1994 to 2023. (C) Visualization map of top 25 keywords with the strongest citation bursts from 1994 to 2023.
FIGURE 1 The development trend of dECM scaffolds. (A) Global trends and (B) research directions in publications and citations of decellularized extracellular matrix analysis in Web of Science from 1994 to 2023. (C) Visualization map of top 25 keywords with the strongest citation bursts from 1994 to 2023.CC BY · PubMed Central
FIGURE 2 Preparation methods of dECM scaffolds. The preparation methods of dECM scaffolds mainly include chemical treatments, enzymatic treatments, physical treatments and new treatments. Chemical treatments: ionic and non‐ionic detergents (SDS, SDC, Triton X‐100, etc.), acids and bases solution (HCl, NH4OH, etc.), hypertonic and hypotonic solutions, organic solvents (ethanol, methyl alcohol, acetone, etc.), chelators (EDTA, EGTA, etc.). Enzymatic treatments: nuclease, trypsin, dispase, lipase, collagenase, α‐Galactosidase, etc. Physical treatments: freeze–thaw cycles, perfusion, mechanically scraping, sonication, electroporation, pressure gradient, immersion and agitation, etc. New treatments: vacuum‐assisted decellularization, apoptosis‐assisted decellularization and supercritical fluids (scCO2). Created with BioRender.com.
FIGURE 2 Preparation methods of dECM scaffolds. The preparation methods of dECM scaffolds mainly include chemical treatments, enzymatic treatments, physical treatments and new treatments. Chemical treatments: ionic and non‐ionic detergents (SDS, SDC, Triton X‐100, etc.), acids and bases solution (HCl, NH4OH, etc.), hypertonic and hypotonic solutions, organic solvents (ethanol, methyl alcohol, acetone, etc.), chelators (EDTA, EGTA, etc.). Enzymatic treatments: nuclease, trypsin, dispase, lipase, collagenase, α‐Galactosidase, etc. Physical treatments: freeze–thaw cycles, perfusion, mechanically scraping, sonication, electroporation, pressure gradient, immersion and agitation, etc. New treatments: vacuum‐assisted decellularization, apoptosis‐assisted decellularization and supercritical fluids (scCO2). Created with BioRender.com.CC BY · PubMed Central
FIGURE 3 Structural and morphological analysis of the dECM scaffolds. (A) HE staining of decellularized rat liver scaffolds. Reproduced with permission.[ 92 ] Copyright 2021, Elsevier. (B) Immunofluorescent staining of decellularized mouse liver scaffolds (collagen IV). Reproduced under Attribution‐Non Commercial‐No Derivs 4.0 International License (CC BY‐NC‐ND 4.0 DEED).[ 113 ] Copyright 2023, The Authors. (C) Immunohistochemical staining of decellularized rat liver scaffolds. Reproduced with permission.[ 92 ] Copyright 2021, Elsevier. (D) SEM imaging of decellularized rat liver scaffolds. Reproduced with permission.[ 92 ] Copyright 2021, Elsevier. (E) AFM imaging of mouse lung ECM. Reproduced under CC BY‐NC‐ND 3.0 License.[ 110 ] Copyright 2010, The Author(s), published by Elsevier. (F) TEM imaging of decellularized rat liver scaffolds. Reproduced with permission.[ 92 ] Copyright 2021, Elsevier. (G) Swept‐source OCT (Optical Coherence Tomography) imaging of 3D bioprinted decellularized collagen grafts implanted into the cornea. Reproduced under the terms of the CC‐BY 4.0 license.[ 114 ] Copyright 2019, The Authors. (H) Cross‐sectional UHR‐SD‐OCT image of membranous septum imaged from left ventricular aspect of a porcine heart. Reproduced with permission.[ 115 ] Copyright 2022, Optica Publishing Group. (I) Wide‐angle synchrotron X‐ray scattering pattern from the central cornea. Reproduced with permission.[ 111 ] Copyright 2004, Elsevier. (J) Representative 3D reconstructed micro‐CT images 8 weeks after the implantation of SIS‐based scaffolds. The new bone formation ratio. Reproduced under the terms of the Creative Commons Attribution License (CC BY).[ 116 ] Copyright 2022, The Authors. (K) Confocal Raman microscopy analysis of ECM derived from decellularized bovine endometrium. Reproduced under the terms of the Creative Commons Attribution License.[ 107 ] Copyright 2021, Simsa et al. (L) Birefringence polarization imaging of healthy rat hearts. Reproduced under the terms of the Creative Commons Attribution License (CC BY).[ 108 ] Copyright 2021, The Author(s). (M) Second harmonic generation imaging of alcoholic cirrhosis in patients. Reproduced under the terms of the Creative Commons Attribution License (CC BY).[ 109 ] Copyright 2023, The Authors.
FIGURE 3 Structural and morphological analysis of the dECM scaffolds. (A) HE staining of decellularized rat liver scaffolds. Reproduced with permission.[ 92 ] Copyright 2021, Elsevier. (B) Immunofluorescent staining of decellularized mouse liver scaffolds (collagen IV). Reproduced under Attribution‐Non Commercial‐No Derivs 4.0 International License (CC BY‐NC‐ND 4.0 DEED).[ 113 ] Copyright 2023, The Authors. (C) Immunohistochemical staining of decellularized rat liver scaffolds. Reproduced with permission.[ 92 ] Copyright 2021, Elsevier. (D) SEM imaging of decellularized rat liver scaffolds. Reproduced with permission.[ 92 ] Copyright 2021, Elsevier. (E) AFM imaging of mouse lung ECM. Reproduced under CC BY‐NC‐ND 3.0 License.[ 110 ] Copyright 2010, The Author(s), published by Elsevier. (F) TEM imaging of decellularized rat liver scaffolds. Reproduced with permission.[ 92 ] Copyright 2021, Elsevier. (G) Swept‐source OCT (Optical Coherence Tomography) imaging of 3D bioprinted decellularized collagen grafts implanted into the cornea. Reproduced under the terms of the CC‐BY 4.0 license.[ 114 ] Copyright 2019, The Authors. (H) Cross‐sectional UHR‐SD‐OCT image of membranous septum imaged from left ventricular aspect of a porcine heart. Reproduced with permission.[ 115 ] Copyright 2022, Optica Publishing Group. (I) Wide‐angle synchrotron X‐ray scattering pattern from the central cornea. Reproduced with permission.[ 111 ] Copyright 2004, Elsevier. (J) Representative 3D reconstructed micro‐CT images 8 weeks after the implantation of SIS‐based scaffolds. The new bone formation ratio. Reproduced under the terms of the Creative Commons Attribution License (CC BY).[ 116 ] Copyright 2022, The Authors. (K) Confocal Raman microscopy analysis of ECM derived from decellularized bovine endometrium. Reproduced under the terms of the Creative Commons Attribution License.[ 107 ] Copyright 2021, Simsa et al. (L) Birefringence polarization imaging of healthy rat hearts. Reproduced under the terms of the Creative Commons Attribution License (CC BY).[ 108 ] Copyright 2021, The Author(s). (M) Second harmonic generation imaging of alcoholic cirrhosis in patients. Reproduced under the terms of the Creative Commons Attribution License (CC BY).[ 109 ] Copyright 2023, The Authors.CC BY · PubMed Central
FIGURE 4 The matrisome analysis workflow diagram. (A) The analysis of matrix composition of dECM consists of four steps: decellularization, extraction of ECM protein, enzymatic hydrolysis and mass spectrometry analysis. (B) The matrisome consists of core matrisome proteins and matrisome‐associated proteins, where core matrisome proteins includes collagens, proteoglycans, glycoproteins, and matrisome‐associated proteins includes ECM regulators, ECM‐affiliated proteins, secreted factors. Created with BioRender.com.
FIGURE 4 The matrisome analysis workflow diagram. (A) The analysis of matrix composition of dECM consists of four steps: decellularization, extraction of ECM protein, enzymatic hydrolysis and mass spectrometry analysis. (B) The matrisome consists of core matrisome proteins and matrisome‐associated proteins, where core matrisome proteins includes collagens, proteoglycans, glycoproteins, and matrisome‐associated proteins includes ECM regulators, ECM‐affiliated proteins, secreted factors. Created with BioRender.com.CC BY · PubMed Central
FIGURE 5 Diverse application forms of decellularized scaffolds. The application forms of decellularized scaffolds mainly include four aspects: whole‐organ level recellularization, powderization, hydrogels fabrication and 3D bioprinting inks. Created with BioRender.com.
FIGURE 5 Diverse application forms of decellularized scaffolds. The application forms of decellularized scaffolds mainly include four aspects: whole‐organ level recellularization, powderization, hydrogels fabrication and 3D bioprinting inks. Created with BioRender.com.CC BY · PubMed Central
FIGURE 6 Applications of decellularized scaffolds in tissue engineering. (A) The decellularized heart scaffold was recellulated to form (a,b) a working perfusion bioartificial heart‐like structure, which showed (c) electrical response and contractile function. Reproduced with permission.[ 148 ] Copyright 2008, Springer Nature. (B) After recellularization, the decellularized liver matrix produces transplantable liver grafts to support liver‐specific functions, including albumin secretion and urea synthesis. Reproduced with permission.[ 189 ] Copyright 2018, American Chemical Society. (a) Photograph of circulating perfusion system and the TE liver after recellularization with ≈30 million hepatocytes. (b) Analysis of albumin secretion and urea synthesis of HepG2 cells under 2D, TE, and TEF liver cultures. (C) The decellularized lung scaffold performs gas exchange function after implantation by epithelial cells and endothelial cells. Reproduced with permission.[ 175 ] Copyright 2010, Springer Nature. (a) Fluorescence micrographs of reendothelialized lung constructs (scale bars, 200 µm). (b) H&E‐stained low‐ (×10) and high‐power views (×40, insets) of A549‐seeded lung constructs (scale bars, 200 µm). (c) Blood gas analyses of pulmonary venous effluent, the dynamic pressure/volume relationship during five respiratory cycles and vital capacity of native lung, HUVEC‐ and A549‐seeded lung (H‐A549), and HUVEC‐ and fetal lung cell–seeded lung (H‐FLC). (D) By the recellularization of epithelial cells and endothelial cells, the decellularized scaffolds of rat kidney were transformed into bioengineered kidney grafts with the function of urine production after orthotopic transplantation. Reproduced with permission.[ 171 ] Copyright 2013, Springer Nature. (a) Schematic of cell seeding and whole organ culture of decellularized rat kidneys. (b) Average urine flow rate (mL min−1), average creatinine clearance and vascular resistance for decellularized, cadaveric, and regenerated kidneys perfused at 80 mmHg and regenerated kidneys perfused at 120 mmHg (regenerated*). (E) The bioscaffolds derived from the central nervous system have cytocompatibility after co‐culture with PC12 cell lines in vitro, and stimulate proliferation, migration and differentiation, thus contributing to functional recovery after CNS injury. Reproduced with permission.[ 177 ] Copyright 2012, Elsevier. (a) Cytocompatibility of CNS ECM scaffolds. Magnification is 400×. (b) Mitogenic effects and chemotactic effects of CNS ECM scaffolds. (F) The Gel‐dECM‐Qcs (GDQ) composite scaffold formed by 3D printing technology combining decellularized pig skin scaffold, temperature sensitive gelatin (Gel) and quaternized chitosan has good mechanical properties, biocompatibility and antibacterial ability. Reproduced with permission.[ 182 ] Copyright 2023, Elsevier. (a) Live/dead staining of L929 cells in different pure/composite scaffolds including Gel, Gel‐dECM and Gel‐dECM‐Qcs. Scale bar = 500 µm. (b) Representative images of colony count of the scaffolds against Escherichia coli and Staphylococcus aureus. Organ schematic images from BioRender.com.
FIGURE 6 Applications of decellularized scaffolds in tissue engineering. (A) The decellularized heart scaffold was recellulated to form (a,b) a working perfusion bioartificial heart‐like structure, which showed (c) electrical response and contractile function. Reproduced with permission.[ 148 ] Copyright 2008, Springer Nature. (B) After recellularization, the decellularized liver matrix produces transplantable liver grafts to support liver‐specific functions, including albumin secretion and urea synthesis. Reproduced with permission.[ 189 ] Copyright 2018, American Chemical Society. (a) Photograph of circulating perfusion system and the TE liver after recellularization with ≈30 million hepatocytes. (b) Analysis of albumin secretion and urea synthesis of HepG2 cells under 2D, TE, and TEF liver cultures. (C) The decellularized lung scaffold performs gas exchange function after implantation by epithelial cells and endothelial cells. Reproduced with permission.[ 175 ] Copyright 2010, Springer Nature. (a) Fluorescence micrographs of reendothelialized lung constructs (scale bars, 200 µm). (b) H&E‐stained low‐ (×10) and high‐power views (×40, insets) of A549‐seeded lung constructs (scale bars, 200 µm). (c) Blood gas analyses of pulmonary venous effluent, the dynamic pressure/volume relationship during five respiratory cycles and vital capacity of native lung, HUVEC‐ and A549‐seeded lung (H‐A549), and HUVEC‐ and fetal lung cell–seeded lung (H‐FLC). (D) By the recellularization of epithelial cells and endothelial cells, the decellularized scaffolds of rat kidney were transformed into bioengineered kidney grafts with the function of urine production after orthotopic transplantation. Reproduced with permission.[ 171 ] Copyright 2013, Springer Nature. (a) Schematic of cell seeding and whole organ culture of decellularized rat kidneys. (b) Average urine flow rate (mL min−1), average creatinine clearance and vascular resistance for decellularized, cadaveric, and regenerated kidneys perfused at 80 mmHg and regenerated kidneys perfused at 120 mmHg (regenerated*). (E) The bioscaffolds derived from the central nervous system have cytocompatibility after co‐culture with PC12 cell lines in vitro, and stimulate proliferation, migration and differentiation, thus contributing to functional recovery after CNS injury. Reproduced with permission.[ 177 ] Copyright 2012, Elsevier. (a) Cytocompatibility of CNS ECM scaffolds. Magnification is 400×. (b) Mitogenic effects and chemotactic effects of CNS ECM scaffolds. (F) The Gel‐dECM‐Qcs (GDQ) composite scaffold formed by 3D printing technology combining decellularized pig skin scaffold, temperature sensitive gelatin (Gel) and quaternized chitosan has good mechanical properties, biocompatibility and antibacterial ability. Reproduced with permission.[ 182 ] Copyright 2023, Elsevier. (a) Live/dead staining of L929 cells in different pure/composite scaffolds including Gel, Gel‐dECM and Gel‐dECM‐Qcs. Scale bar = 500 µm. (b) Representative images of colony count of the scaffolds against Escherichia coli and Staphylococcus aureus. Organ schematic images from BioRender.com.CC BY · PubMed Central
FIGURE 7 Applications of decellularized scaffolds in organoid culture. (A) Representative images of lung organoids encapsulated in A‐dECM and D‐dECM hydrogels and stained for calcein‐AM (green) and PI (red) on day 10. Reproduced under the terms of the CC‐BY 4.0 License.[ 197 ] Copyright 2023, The Authors. (B) Human pediatric gastric enteroids in ECM gel (a), and forming mouse intestinal organoids per field of view at day 4 of culture in ECM gel and Matrigel over two passages (b). Reproduced under a Creative Commons Attribution 4.0 International License.[ 195 ] Copyright 2019, The Authors. (C) Brain organoids on day 10 in Matrigel (top pictures) or B‐ECM hydrogel (bottom pictures). On day 40, no significant difference is apparent. White arrows at day 10 point to ventricular‐like zones located in the formed neuronal buds. White arrowhead at day 40 indicates residual B‐ECM hydrogel. Reproduced under the terms of the Creative Commons Attribution License.[ 198 ] Copyright 2021, The Authors. (D) Tissue sections of brain organoids cultured in Matrigel (left panels) or B‐ECM hydrogel (right panels) for 40 days were immunostained for neuronal progenitor markers (SOX2, Nestin, PAX6) and mature neuronal markers (DCX, β‐Tubulin III, MAP2). DAPI was used as nuclear counterstaining. White arrowheads indicate ventricular like zones that were chosen for magnification. Reproduced under the terms of the Creative Commons Attribution License.[ 198 ] Copyright 2021,The Authors. (E) Bright‐field images of mouse endometrial organoids in Matrigel and endometrial hydrogels (P1–P3, a–d). Reproduced under Creative Commons Attribution‐Non Commercial‐No Derivatives License 4.0 (CC BY‐NC‐ND).[ 107 ] Copyright 2022, the Authors. (F) The organoid forming efficiency of mouse endometrial organoids in Matrigel and P1–P3 hydrogel (a); Percentages of organoid nos. representing round, tubular, and glandular‐shaped organoids in Matrigel versus P1 (b). Reproduced under Creative Commons Attribution‐Non Commercial‐No Derivatives License 4.0 (CC BY‐NC‐ND).[ 107 ] Copyright 2022, the Authors. (G) H&E and immunostaining for Foxa2, Ck8, and Ki67 of organoids cultured in Matrigel and P1 hydrogel. Reproduced under Creative Commons Attribution‐Non Commercial‐No Derivatives License 4.0 (CC BY‐NC‐ND).[ 107 ] Copyright 2022, the Authors.
FIGURE 7 Applications of decellularized scaffolds in organoid culture. (A) Representative images of lung organoids encapsulated in A‐dECM and D‐dECM hydrogels and stained for calcein‐AM (green) and PI (red) on day 10. Reproduced under the terms of the CC‐BY 4.0 License.[ 197 ] Copyright 2023, The Authors. (B) Human pediatric gastric enteroids in ECM gel (a), and forming mouse intestinal organoids per field of view at day 4 of culture in ECM gel and Matrigel over two passages (b). Reproduced under a Creative Commons Attribution 4.0 International License.[ 195 ] Copyright 2019, The Authors. (C) Brain organoids on day 10 in Matrigel (top pictures) or B‐ECM hydrogel (bottom pictures). On day 40, no significant difference is apparent. White arrows at day 10 point to ventricular‐like zones located in the formed neuronal buds. White arrowhead at day 40 indicates residual B‐ECM hydrogel. Reproduced under the terms of the Creative Commons Attribution License.[ 198 ] Copyright 2021, The Authors. (D) Tissue sections of brain organoids cultured in Matrigel (left panels) or B‐ECM hydrogel (right panels) for 40 days were immunostained for neuronal progenitor markers (SOX2, Nestin, PAX6) and mature neuronal markers (DCX, β‐Tubulin III, MAP2). DAPI was used as nuclear counterstaining. White arrowheads indicate ventricular like zones that were chosen for magnification. Reproduced under the terms of the Creative Commons Attribution License.[ 198 ] Copyright 2021,The Authors. (E) Bright‐field images of mouse endometrial organoids in Matrigel and endometrial hydrogels (P1–P3, a–d). Reproduced under Creative Commons Attribution‐Non Commercial‐No Derivatives License 4.0 (CC BY‐NC‐ND).[ 107 ] Copyright 2022, the Authors. (F) The organoid forming efficiency of mouse endometrial organoids in Matrigel and P1–P3 hydrogel (a); Percentages of organoid nos. representing round, tubular, and glandular‐shaped organoids in Matrigel versus P1 (b). Reproduced under Creative Commons Attribution‐Non Commercial‐No Derivatives License 4.0 (CC BY‐NC‐ND).[ 107 ] Copyright 2022, the Authors. (G) H&E and immunostaining for Foxa2, Ck8, and Ki67 of organoids cultured in Matrigel and P1 hydrogel. Reproduced under Creative Commons Attribution‐Non Commercial‐No Derivatives License 4.0 (CC BY‐NC‐ND).[ 107 ] Copyright 2022, the Authors.CC BY · PubMed Central

Verification

Claims the paper makes

75 Valid · 35 Not valid · 76 Not checked · 73 Own results and interpretations

90 more claims · 32 with their cited sources checked

Create a free account to see all 259 claims and to verify the 16 references still open.

See all claims — free account
  • Probably not a substantial claim. 82
  • It may state two separate claims as one. 111

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 208 references

Research works printed but not linked: 4

  1. Gilbert T. W., 2006, Biomaterials, 27, 3675
  2. Li N., 2011, Mol. Vis., 17, 1909
  3. Pulver null, 2014, CryoLetters, 35, 400
  4. Russell H. K., 1972, Arch. Pathol., 94, 187

Cited by

Metadata

Authors
Liu, J., Song, Q., Yin, W., Li, C., An, N., Le, Y., Wang, Q., Feng, Y., Hu, Y., & Wang, Y.
Affiliations
  • Beijing Tsinghua Chang Gung Hospital (CN)
  • Beijing University of Technology (CN)
  • Zhejiang Sci-Tech University (CN)
  • Jilin University (CN)
Corresponding author
  • Liu, Juan
  • Wang, Yunfang
Venue
Exploration
Publisher
Wiley
Published
2024-04-11
Volume
5
Issue
1
Pages
20230078-20230078
ISSN
  • 2766-2098 (ISSN-L)
  • 2766-8509
OpenAlex
W4394758519
Cited by
140
References
210
Citations by year
2026: 73 · 2025: 52 · 2024: 15
FWCI
15.44
Type
journal article
Language
en
Open access
Locations
  • Exploration (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (32371477, 92168207, 82090051)
  • National Key Research and Development Program of China (2022YFA1103400, 2022YFC2406704)
Topics
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
Keywords
decellularized extracellular matrix, tissue engineering scaffolds, tissue regeneration, tissue remodeling

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.